Ponoi II Management, LLC 13F Holdings · last filed Q3 2022
Ponoi II Management, LLC reported 4 securities worth $38.26M in its SEC 13F filing for Q3 2022 (period ended 2022-09-30). Top holdings: NGM (44.41%), RVMD (35.31%), NRIX (11.14%).
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | NGM | NGM Biopharmaceuticals Inc | $17.0M | 44.41% | 1.3M | Hold |
| 2 | RVMD | Revolution Medicines Inc | $13.5M | 35.31% | 685,011 | Hold |
| 3 | NRIX | Nurix Therapeutics Inc | $4.3M | 11.14% | 327,123 | Hold |
| 4 | RAPT | RAPT Therapeutics Inc | $3.5M | 9.14% | 145,401 | Hold |
Source: SEC Form 13F filings · as of 2022-09-30
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR